Today at 3 p.m., I will be joining DEA’s Mr. Joseph Rannazzisi, HDMA CEO John Gray and others to testify before the House Energy and Commerce Subcommittee on Health regarding a proposed amendment to the Controlled Substances Act. H.R. 4069, introduced by Representative Tom Marino of Pennsylvania and Representative Marsha Blackburn of Tennessee, defines two key terms in the CSA — “imminent danger” and “consistent with the public interest” — as well as making other changes to strengthen efforts to prevent prescription drug abuse while enhancing patient access to controlled medications. You can watch the hearing on the Ensuring Patient Access and Effective Drug Enforcement Act at 3 p.m … and stay tuned to DEA Chronicles for discussion of this bill.
Hearing on the Ensuring Patient Access and Effective Drug Enforcement Act